Developer docs
API playgroundTry for free, no card

Search company profiles

SmartLabs

Full company profile

uuid0000hr6

Namestring
SmartLabs
Legal namestring
SmartLabs
Websiteurl
smartlabs.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

SmartLabs is a Boston-based private company founded in 2015 that operates a lab-as-a-service platform under the Managed Research Center (MRC) brand. The company delivers enterprise-grade, reconfigurable research infrastructure across five sites (Boston Landing, Kendall Square, South San Francisco, and the new Sydney facility at ION), covering R&D laboratory suites, AAALAC-accredited in vivo/vivarium suites, cGMP CleanSuites for manufacturing up to 500 liters, and a newly launched Deeptech Laboratory line. Its offering bundles flexible physical infrastructure with operations support (EH&S, facilities management, IT, veterinary sciences, lab design) and scientific expertise, with deployment in 2-4 weeks versus multi-year traditional buildouts.

The company monetizes through three primary streams: recurring all-inclusive MRC licensing agreements, fee-for-service Custom Developed Solutions (CDS) for landlords, developers, and institutions, and managed cGMP and in vivo service bundles. Go-to-market is enterprise field sales led by an SVP of Commercial and supported by industry events such as BIO International Convention, with distribution amplified by a 10-year global partnership with IWG (June 2025) and a co-development alliance with Sonrai Analytics for embedded AI precision medicine tooling (August 2025). Customer base spans 120+ clients, including early-stage biotech startups (Entrada Therapeutics, Scorpion Therapeutics, Gritstone bio, Cue Biopharma, HI-Bio) and enterprise pharma (Mitsubishi Tanabe Pharma), across modalities spanning cell and gene therapies, mRNA, antibodies, and small molecules.

SmartLabs has raised over $298 million across multiple funding rounds since 2015, including a $250 million Series B led by ArrowMark Partners in September 2021 and a $48 million extension in January 2024, with a stated objective of expanding to 2 million square feet of lab space over five years. The company's first international research center at ION in Sydney (announced May 2026) is a ~$490 million life sciences precinct developed with Kurraba Group, IWG, and Thermo Fisher Scientific, and represents a template for the global franchise model enabled by the IWG partnership. Leadership is anchored by CEO Brian Taylor (PharmaVoice 100 honoree, formerly GE Healthcare biomanufacturing) and CFO Robin Feeney.

Short descriptiontext

SmartLabs operates a lab-as-a-service platform delivering flexible turnkey research infrastructure, including R&D labs, AAALAC-accredited vivariums, cGMP cleanrooms, and deeptech suites, to 120+ biotech, pharma, and deeptech clients across five research centers in the US and Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lab-as-a-service, managed research centers, biotech lab infrastructure, vivarium research services, cGMP manufacturing suites
Industry3 codes
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAOAI
Laboratory, Bioanalytical & Central Lab Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code4 codes
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Laboratory Infrastructure / Lab-as-a-Service
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Managed Research Center (MRC) Licensing
TypeSubscription Recurring
Description

All-inclusive license agreements providing access to enterprise-grade lab environments, operational support, and scientific expertise. Clients pay recurring fees for flexible commitments without large upfront capital investments. The model covers infrastructure, daily operations, EH&S compliance, IT, and concierge services as a comprehensive package.

smartlabs.com
2Custom Developed Solutions (CDS)
TypeProfessional Services
Description

Fee-for-service model for designing, building, managing, and promoting research facilities for partners anywhere in the world. Services include technical assessments, design consulting, construction management, and operational support — available as a comprehensive package or a la carte solutions.

smartlabs.com
3In Vivo Research Services
TypeManaged Services
Description

Specialized animal research services including AAALAC-accredited vivarium space, veterinary sciences, surgical procedures, imaging services, and regulatory compliance support bundled with lab space access.

smartlabs.com
4cGMP Manufacturing CleanSuites
TypeManaged Services
Description

Managed cleanroom services for clinical and commercial manufacturing, including ISO-7 compliant environments, quality program support, environmental monitoring, and regulatory compliance. Supports manufacturing capacity up to 500 liters.

smartlabs.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SmartLabs builds and operates Managed Research Centers (MRCs) — flexible, enterprise-grade laboratory environments combined with concierge-level operational support and scientific expertise delivered as a lab-as-a-service model. Clients access private R&D labs, AAALAC-accredited vivarium suites, and ISO-compliant cGMP manufacturing cleanrooms without upfront capital investment, with labs ready in 2-4 weeks and reconfigurable on demand as research evolves.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Labs ready in 2-4 weeks vs. 4+ years for traditional buildout
+4 more records
Product and service2 records
1Managed Research Centers (MRC)
CategoryLab-as-a-Service Platform
Description

Hybrid research center model offering enterprise-grade lab environments, expert operational support, and scientific expertise for biotech, pharma, and deeptech companies. MRCs feature flexible, reconfigurable space that adapts as research evolves and is delivered ready in 2-4 weeks without upfront capital investment, with services covering infrastructure, daily operations, EH&S compliance, IT, and concierge support.

2R&D Laboratory Suites
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Kurraba Group
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-05
Description

Partnership with Australian innovation, life sciences, and education real estate firm to develop ION, Sydney's first purpose-built commercial life sciences precinct. SmartLabs, IWG, and Thermo Fisher Scientific were secured as inaugural partners for the approximately $490 million project delivering 27,000+ sqm of lab-enabled space.

smartlabs.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-05
Description

Thermo Fisher Scientific joined as an inaugural partner for ION in Sydney, providing technologies, services, and operational support across the full innovation lifecycle from early discovery through manufacturing.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-05-05
Description

Buildcorp appointed as builder for ION project with strong track record delivering technically complex commercial and institutional projects across Australia. Construction expected to commence in coming months with project delivery targeted for Q4 2028.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-28
Description

Global strategic partnership integrating Sonrai's AI precision medicine platform (Sonrai Discovery) into SmartLabs' five managed research centers. Both companies will develop new laboratory informatics and bespoke AI applications integrating experimental and infrastructure data to predict scientific outcomes and accelerate discovery, exclusively available to SmartLabs members.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-06-17
Description

10-year global partnership integrating SmartLabs' lab-as-a-service solutions across IWG's global portfolio of flexible workspace brands (Regus, Spaces, Signature, HQ) in 120+ countries. SmartLabs delivers site selection, lab design, construction management, daily operations, and scientific support while IWG provides global distribution reach and platform access.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Non-profit biotech incubator operating shared lab facilities in Cambridge, MA. Provides coworking lab space and operational support to early-stage biotech startups — directly comparable to SmartLabs' MRC model and overlapping customer base in Kendall Square.

TypeDirect peer
Description

Coworking laboratory operator with locations in multiple US and European biotech hubs. Offers shared lab infrastructure and operational services to biotech startups — directly competitive with SmartLabs' lab-as-a-service offering for early-stage companies.

TypeDirect peer
Description

San Francisco Bay Area-based coworking lab operator providing turnkey lab facilities to biotech startups. Direct peer targeting the same startup biotech customer segment with comparable lab-as-a-service economics.

TypeBroad incumbent
Description

Public REIT (NYSE: ARE) specializing in collaborative life sciences campuses in major innovation hubs. Provides purpose-built lab and office space to large pharma and mature biotech — competing with SmartLabs for enterprise customers and long-term lease relationships.

TypeBroad incumbent
Description

Private life sciences real estate platform (owned by Blackstone) operating lab and office properties in key biotech clusters. Broad incumbent serving large pharma and biotech with traditional long-term lease models that compete for the same enterprise client base.

TypeDirect peer
Description

Operator of innovation campuses providing flexible office, lab, and venture development space to startups and growth companies. Comparable model in delivering turnkey infrastructure to early-stage science companies, with overlap in Cambridge/Boston geography.

TypeBroad incumbent
Description

Global CRO/CDMO providing research models, preclinical, and manufacturing services to biopharma. Overlaps with SmartLabs' in vivo and cGMP manufacturing offerings as a broader services incumbent — different model (fee-for-service) but competes for adjacent biopharma budgets.

TypeBroad incumbent
Description

Global life sciences services company offering clinical research, laboratory, and technology services. Broad incumbent in life sciences services with potential overlap in central lab and clinical research support — competes for biopharma spend though with a different delivery model.

TypeBroad incumbent
Description

Global CRO/CDMO providing discovery, development, and manufacturing services across small and large molecules. Competes with SmartLabs' cGMP manufacturing and lab services offerings for biotech and pharma clients, particularly those seeking outsourced R&D and production capacity.

10ShareSpace (or similar coworking lab concept in EU/UK)
TypeRegional player
Description

UK-based flexible lab and office operator providing shared infrastructure to science startups. Comparable coworking lab concept serving European biotech startups — competes with SmartLabs' potential IWG-enabled UK and European expansion.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SmartLabs

Laboratory Infrastructure / Lab-as-a-Servicesmartlabs.com

SmartLabs operates a lab-as-a-service platform delivering flexible turnkey research infrastructure, including R&D labs, AAALAC-accredited vivariums, cGMP cleanrooms, and deeptech suites, to 120+ biotech, pharma, and deeptech clients across five research centers in the US and Australia.

What SmartLabs does

SmartLabs is a Boston-based private company founded in 2015 that operates a lab-as-a-service platform under the Managed Research Center (MRC) brand. The company delivers enterprise-grade, reconfigurable research infrastructure across five sites (Boston Landing, Kendall Square, South San Francisco, and the new Sydney facility at ION), covering R&D laboratory suites, AAALAC-accredited in vivo/vivarium suites, cGMP CleanSuites for manufacturing up to 500 liters, and a newly launched Deeptech Laboratory line. Its offering bundles flexible physical infrastructure with operations support (EH&S, facilities management, IT, veterinary sciences, lab design) and scientific expertise, with deployment in 2-4 weeks versus multi-year traditional buildouts.

The company monetizes through three primary streams: recurring all-inclusive MRC licensing agreements, fee-for-service Custom Developed Solutions (CDS) for landlords, developers, and institutions, and managed cGMP and in vivo service bundles. Go-to-market is enterprise field sales led by an SVP of Commercial and supported by industry events such as BIO International Convention, with distribution amplified by a 10-year global partnership with IWG (June 2025) and a co-development alliance with Sonrai Analytics for embedded AI precision medicine tooling (August 2025). Customer base spans 120+ clients, including early-stage biotech startups (Entrada Therapeutics, Scorpion Therapeutics, Gritstone bio, Cue Biopharma, HI-Bio) and enterprise pharma (Mitsubishi Tanabe Pharma), across modalities spanning cell and gene therapies, mRNA, antibodies, and small molecules.

SmartLabs has raised over $298 million across multiple funding rounds since 2015, including a $250 million Series B led by ArrowMark Partners in September 2021 and a $48 million extension in January 2024, with a stated objective of expanding to 2 million square feet of lab space over five years. The company's first international research center at ION in Sydney (announced May 2026) is a ~$490 million life sciences precinct developed with Kurraba Group, IWG, and Thermo Fisher Scientific, and represents a template for the global franchise model enabled by the IWG partnership. Leadership is anchored by CEO Brian Taylor (PharmaVoice 100 honoree, formerly GE Healthcare biomanufacturing) and CFO Robin Feeney.

SmartLabs firmographics

Firmographics
Name
SmartLabs
Legal name
SmartLabs
Website
https://smartlabs.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
SmartLabs operates a lab-as-a-service platform delivering flexible turnkey research infrastructure, including R&D labs, AAALAC-accredited vivariums, cGMP cleanrooms, and deeptech suites, to 120+ biotech, pharma, and deeptech clients across five research centers in the US and Australia.
Ownership category
akta.pro rank

SmartLabs industry classification

Industry
Product category
Laboratory Infrastructure / Lab-as-a-Service
NAICS
Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAOAI
Laboratory, Bioanalytical & Central Lab Staffing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Lab-as-a-service
  • Managed research centers
  • Biotech lab infrastructure
  • Vivarium research services
  • CGMP manufacturing suites

Where SmartLabs is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices4 records

Markets served

SmartLabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Managed Research Center (MRC) Licensing: All-inclusive license agreements providing access to enterprise-grade lab environments, operational support, and scientific expertise. Clients pay recurring fees for flexible commitments without large upfront capital investments. The model covers infrastructure, daily operations, EH&S compliance, IT, and concierge services as a comprehensive package.
  2. Custom Developed Solutions (CDS): Fee-for-service model for designing, building, managing, and promoting research facilities for partners anywhere in the world. Services include technical assessments, design consulting, construction management, and operational support — available as a comprehensive package or a la carte solutions.
  3. In Vivo Research Services: Specialized animal research services including AAALAC-accredited vivarium space, veterinary sciences, surgical procedures, imaging services, and regulatory compliance support bundled with lab space access.
  4. cGMP Manufacturing CleanSuites: Managed cleanroom services for clinical and commercial manufacturing, including ISO-7 compliant environments, quality program support, environmental monitoring, and regulatory compliance. Supports manufacturing capacity up to 500 liters.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

SmartLabs product offering

Product offering

Core offering

SmartLabs builds and operates Managed Research Centers (MRCs) — flexible, enterprise-grade laboratory environments combined with concierge-level operational support and scientific expertise delivered as a lab-as-a-service model. Clients access private R&D labs, AAALAC-accredited vivarium suites, and ISO-compliant cGMP manufacturing cleanrooms without upfront capital investment, with labs ready in 2-4 weeks and reconfigurable on demand as research evolves.

Differentiator

Problem solved

Functional benefit

Products and services

  • Managed Research Centers (MRC) Hybrid research center model offering enterprise-grade lab environments, expert operational support, and scientific expertise for biotech, pharma, and deeptech companies. MRCs feature flexible, reconfigurable space that adapts as research evolves and is delivered ready in 2-4 weeks without upfront capital investment, with services covering infrastructure, daily operations, EH&S compliance, IT, and concierge support.
  • R&D Laboratory Suites

Quantifiable outcome

  • Labs ready in 2-4 weeks vs. 4+ years for traditional buildout
  • +4 more outcomes

Companies that use SmartLabs

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

SmartLabs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

SmartLabs partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship, core and minor.

  • Kurraba GroupflagshipStrategic or Co-development Partner · 5 May 2026Partnership with Australian innovation, life sciences, and education real estate firm to develop ION, Sydney's first purpose-built commercial life sciences precinct. SmartLabs, IWG, and Thermo Fisher Scientific were secured as inaugural partners for the approximately $490 million project delivering 27,000+ sqm of lab-enabled space.
  • Thermo Fisher ScientificcoreTechnology or Integration · 5 May 2026Thermo Fisher Scientific joined as an inaugural partner for ION in Sydney, providing technologies, services, and operational support across the full innovation lifecycle from early discovery through manufacturing.
  • BuildcorpminorImplementation/ SI/ Consulting Partner · 5 May 2026Buildcorp appointed as builder for ION project with strong track record delivering technically complex commercial and institutional projects across Australia. Construction expected to commence in coming months with project delivery targeted for Q4 2028.
  • Sonrai AnalyticscoreTechnology or Integration · 28 August 2025Global strategic partnership integrating Sonrai's AI precision medicine platform (Sonrai Discovery) into SmartLabs' five managed research centers. Both companies will develop new laboratory informatics and bespoke AI applications integrating experimental and infrastructure data to predict scientific outcomes and accelerate discovery, exclusively available to SmartLabs members.
  • International Workplace Group (IWG)flagshipStrategic or Co-development Partner · 17 June 202510-year global partnership integrating SmartLabs' lab-as-a-service solutions across IWG's global portfolio of flexible workspace brands (Regus, Spaces, Signature, HQ) in 120+ countries. SmartLabs delivers site selection, lab design, construction management, daily operations, and scientific support while IWG provides global distribution reach and platform access.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

SmartLabs competitors and assessment

Company assessment

Direct peers

  • LabCentral: Non-profit biotech incubator operating shared lab facilities in Cambridge, MA. Provides coworking lab space and operational support to early-stage biotech startups — directly comparable to SmartLabs' MRC model and overlapping customer base in Kendall Square.
  • Biolabs (now part of Life Science Cares): Coworking laboratory operator with locations in multiple US and European biotech hubs. Offers shared lab infrastructure and operational services to biotech startups — directly competitive with SmartLabs' lab-as-a-service offering for early-stage companies.
  • MBC BioLabs: San Francisco Bay Area-based coworking lab operator providing turnkey lab facilities to biotech startups. Direct peer targeting the same startup biotech customer segment with comparable lab-as-a-service economics.
  • Cambridge Innovation Center (CIC): Operator of innovation campuses providing flexible office, lab, and venture development space to startups and growth companies. Comparable model in delivering turnkey infrastructure to early-stage science companies, with overlap in Cambridge/Boston geography.

Broad incumbents

  • Alexandria Real Estate Equities: Public REIT (NYSE: ARE) specializing in collaborative life sciences campuses in major innovation hubs. Provides purpose-built lab and office space to large pharma and mature biotech — competing with SmartLabs for enterprise customers and long-term lease relationships.
  • BioMed Realty: Private life sciences real estate platform (owned by Blackstone) operating lab and office properties in key biotech clusters. Broad incumbent serving large pharma and biotech with traditional long-term lease models that compete for the same enterprise client base.
  • Charles River Laboratories: Global CRO/CDMO providing research models, preclinical, and manufacturing services to biopharma. Overlaps with SmartLabs' in vivo and cGMP manufacturing offerings as a broader services incumbent — different model (fee-for-service) but competes for adjacent biopharma budgets.
  • IQVIA: Global life sciences services company offering clinical research, laboratory, and technology services. Broad incumbent in life sciences services with potential overlap in central lab and clinical research support — competes for biopharma spend though with a different delivery model.
  • WuXi AppTec: Global CRO/CDMO providing discovery, development, and manufacturing services across small and large molecules. Competes with SmartLabs' cGMP manufacturing and lab services offerings for biotech and pharma clients, particularly those seeking outsourced R&D and production capacity.

Regional players

  • ShareSpace (or similar coworking lab concept in EU/UK): UK-based flexible lab and office operator providing shared infrastructure to science startups. Comparable coworking lab concept serving European biotech startups — competes with SmartLabs' potential IWG-enabled UK and European expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

SmartLabs social profiles

Digital presence

SmartLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SmartLabs leadership team

Management profile

Number of profiles

Profiles4 records

SmartLabs funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SmartLabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SmartLabs

What does SmartLabs do?

SmartLabs builds and operates Managed Research Centers (MRCs) — flexible, enterprise-grade laboratory environments combined with concierge-level operational support and scientific expertise delivered as a lab-as-a-service model. Clients access private R&D labs, AAALAC-accredited vivarium suites, and ISO-compliant cGMP manufacturing cleanrooms without upfront capital investment, with labs ready in 2-4 weeks and reconfigurable on demand as research evolves.

Is SmartLabs a public or private company?

SmartLabs is a private company. It is classified as venture growth investor backed and is currently operating.

When was SmartLabs founded?

SmartLabs was founded in 2015. It employs 101 to 250 people.

Where is SmartLabs based?

SmartLabs is headquartered in Boston, United States, in the North America region.

How does SmartLabs make money?

Four revenue lines are on record. Managed Research Center (MRC) Licensing is the primary driver. The others are custom Developed Solutions (CDS), in Vivo Research Services and cGMP Manufacturing CleanSuites.

Who are SmartLabs's main competitors?

Direct peers on record are LabCentral, Biolabs (now part of Life Science Cares), MBC BioLabs and Cambridge Innovation Center (CIC). Broad incumbents are Alexandria Real Estate Equities, BioMed Realty, Charles River Laboratories, IQVIA and WuXi AppTec. ShareSpace (or similar coworking lab concept in EU/UK) is listed as a regional player.

Does SmartLabs have an API?

No public API is recorded for SmartLabs.

What industry is SmartLabs in?

SmartLabs's product category is Laboratory Infrastructure / Lab-as-a-Service. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BisnowFlexible Lab Provider Closing 84K SF Boston LocationSmartLabs is closing its 84K SF flexible lab space at 40 Guest St. in Boston Landing, Brighton. The building, owned by NB Development Group, had remaining tenants seeking new space. The closure follows legal issues and lease terminations, with the company's only remaining Boston-area location at 301 Binney St.News-MedicalION secures first global partners, advancing Australia's next generation of life sciences innovationKurraba Group announced the first confirmed global partners for ION, a purpose-built commercial life sciences precinct in Waterloo, Sydney, Australia, with SmartLabs, International Workplace Group (IWG), and Thermo Fisher Scientific signing on as inaugural partners. The approximately $490 million project will deliver more than 27,000 sqm of lab-enabled space across a multi-building precinct, introducing SmartLabs' globally recognized "lab-as-a-service" model to the Australian market for the first time. Construction is expected to commence in the coming months, with project delivery targeted for Q4 2028.CFOtech AustraliaKurraba signs first tenants for Sydney life sciences hubKurraba Group has secured SmartLabs, IWG, and Thermo Fisher Scientific as the inaugural tenants for its AUD $490 million ION life sciences precinct in Waterloo, Sydney. This development introduces a 'lab-as-a-service' model to Australia, aiming to provide specialized laboratory infrastructure that supports the local biotech and pharmaceutical sectors. The project is designed to bridge the gap between research and commercialization by offering flexible, high-quality scientific facilities.BisnowBioMed Sues Flexible Lab Operator Over Unpaid RentBioMed Realty has filed a lawsuit against SmartLabs, accusing the flexible life sciences workspace provider of breaching its lease and failing to pay $2.7 million in rent and fees for a property in Cambridge. The complaint highlights SmartLabs' alleged financial mismanagement, including moving funds between its entities, and follows a history of unpaid rent and a previous lease termination by BioMed. These financial troubles for SmartLabs come amidst a challenging market for life sciences and declining venture capital funding in the biotech sector.American City Business JournalsBioMed Realty sues SmartLabs for unpaid rentBioMed Realty has filed a lawsuit against SmartLabs for unpaid rent after SmartLabs shut down two operations in South San Francisco. The closure of these operations indicates potential financial difficulties for SmartLabs.American City Business JournalsBioMed Realty sues SmartLabs for unpaid rentBioMed Realty has filed a lawsuit against SmartLabs for approximately $2.7 million in unpaid rent related to their lease at the Sidney Research Campus in Cambridge. The complaint alleges that SmartLabs has repeatedly failed to pay rent and engaged in questionable financial practices, including moving money between affiliates to avoid payment obligations. The lawsuit also follows a pattern of financial difficulties for SmartLabs, despite recent capital raises.Coherent Market InsightsCoworking Spaces Market Size, Trends & Forecast, 2025-2032A market report forecasts the global coworking spaces market to grow from USD 25.39 billion in 2025 to USD 62.76 billion by 2032, driven by hybrid work adoption and startup growth. Key industry developments include CBRE's acquisition of Industrious and a strategic partnership between SmartLabs and IWG to expand lab-enabled workspace offerings.Clinical Lab ProductsSmartLabs Partners with Sonrai to Integrate AI Analytics PlatformSmartLabs has partnered with Sonrai to integrate AI analytics into its network of research centers. The collaboration aims to accelerate biomarker discovery and diagnostic workflows for biotech and pharmaceutical companies by offering Sonrai's AI platform, Sonrai Discovery.PR NewswireSmartLabs und Sonrai gehen exklusive Partnerschaft ein, um den Mitgliedsunternehmen von SmartLabs fortschrittliche KI-Fähigkeiten zur Verfügung zu stellenSmartLabs and Sonrai Analytics announced on August 28, 2025 a global strategic partnership to integrate Sonrai's AI-based analysis platform Sonrai Discovery into SmartLabs' network of five managed research centers. Under the agreement, SmartLabs will offer its member companies access to the platform along with exclusive informatics and AI applications developed jointly by both companies. The partnership aims to accelerate scientific discoveries by enabling member companies to manage complex data at scale and identify patterns and biomarkers more efficiently.PR NewswireSmartLabs et Sonrai lancent un partenariat exclusif pour offrir des capacités d'IA avancées aux sociétés membres de SmartLabsSmartLabs and Sonrai Analytics announced a global strategic partnership on August 28, 2025, integrating Sonrai's AI-powered data management platform, Sonrai Discovery, into SmartLabs' network of five advanced research centers. SmartLabs will offer Sonrai's analytics platform to its member companies and the two firms will jointly develop exclusive AI and laboratory computing applications designed to accelerate scientific discovery and biomarker identification. The partnership represents SmartLabs' expansion into AI-driven research solutions to meet growing demand from biotech and pharmaceutical companies for advanced data analytics capabilities.